Arrowhead Research | ARWR - الدائنين التجاريين





الدائنين التجاريين تغيير تاريخ
Agios Pharmaceuticals USD 16.34M 2.6M 2026-06
Alnylam Pharmaceuticals USD 108.02M 18.61M 2026-06
Anika Therapeutics USD 6.24M 103K 2026-06
Arrowhead Research USD 30.75M 2.19M 2026-03
Heron Therapeutics USD 8.97M 24K 2026-03
Incyte USD 1.39B 1.16B 2026-06
Ionis Pharmaceuticals USD 47.7M 21.67M 2026-06
Ligand Pharmaceuticals USD 37.11M 33.87M 2026-03
Merck USD 3.86B 541M 2026-03
Moderna USD 167M 6M 2026-06
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Novartis USD 4.26B 64M 2026-06
Sarepta Therapeutics USD 70.38M 210.46M 2026-03
TG Therapeutics USD 148.84M 41.34M 2026-03
Ultragenyx Pharmaceutical USD 42M 11M 2026-03
Vertex Pharmaceuticals USD 3.47B 40.6M 2026-03
Xencor USD 7.92M 2.91M 2026-03